determining the prevalence of mgus & deciphering the mechanisms of disease progression
Published 1 year ago • 174 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:43
an insight into the prevalence of various subtypes of mgus in the istopmm study
-
1:50
insights into the mechanisms leading to progression from mgus and smm to multiple myeloma
-
4:39
predicting progression of mgus/smm
-
2:18
blood screening for mgus: preventing progression with promise
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
4:41
first results of promise: mgus screening in a high-risk population
-
1:36
multivariate model to predict the need for bone marrow sampling in patients with mgus
-
18:01
1 year anniversary with monoclonal gammopathy (mgus)
-
5:30
changing perceptions of mgus progression: explaining the data
-
7:36
disease associations with mgus
-
1:26
incidence and risk factors associated with vod/sos in younger vs older adults after sct
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
2:19
hematology in focus: mgus with clinical significance
-
1:00
proof of principle to progress treatments
-
2:16
what does the future of mgus look like?
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:38
the genomic definition of high-risk myeloma
-
0:53
using single-cell sequencing to define mechanisms of progression from smm to myeloma
-
5:11
istopmm: the psychological effects of mgus screening and changes to clinical presentation of myeloma
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
0:52
using spatial proteomics to analyze the bone marrow microenvironment in smm treated with nivolumab
-
2:37
meta-analysis of studies on biomarker-defined early multiple myeloma